Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.89 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 85/100

Amedisys Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2021 / 07:40PM GMT
Release Date Price: €157 (+0.64%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Hi, everyone. Thanks for dialing in for our next presentation. We're very happy to have Amedisys with us tonight, this afternoon. And representing Amedisys is Paul Kusserow, President and CEO; Chris Gerard, Chief Operating Officer; Scott Ginn, Chief Financial Officer; and Nick Muscato, Chief of Staff and VP of Strategic Finance. This is going to be a fireside chat Q&A. (Operator Instructions)

I have plenty of questions so.

Questions & Answers

Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

And I'm going to just jump off of the third quarter. Some of this is pretty specific, but I think it's all stuff that we've been asking helpful hopefully and paints the picture of where things stand. I think if we go back to the second quarter, Amedisys had identified about 54 hospice locations that were substantially below the company's norm for ADC at less than 45.

Have you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot